# De-escalation Study for Stage IIa/IIb < 3 cm Seminoma

> **NCT05529251** · PHASE2 · RECRUITING · sponsor: **Centre Leon Berard** · enrollment: 90 (estimated)

## Conditions studied

- Seminoma
- Stage II

## Interventions

- **RADIATION:** Radiotherapy boost
- **DRUG:** Carboplatin AUC7
- **DRUG:** 3 cycles of EP

## Key facts

- **NCT ID:** NCT05529251
- **Lead sponsor:** Centre Leon Berard
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-09-06
- **Primary completion:** 2025-09-06
- **Final completion:** 2030-09-06
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2024-01-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05529251

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05529251, "De-escalation Study for Stage IIa/IIb < 3 cm Seminoma". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05529251. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*